KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has agreed to acquire KalVista Pharmaceuticals, a pharmacy business in the United States, for $27.00. KalVista Pharmaceuticals develops specialty medicines and therapies, supporting Chiesi Farmaceutici acquisitions in the healthcare sector. The KalVista Pharmaceuticals acquisition expands Chiesi’s strategic acquisition footprint in pharmacy and strengthens its pipeline and commercial capabilities. The merger acquisition is announced, structured as a strategic acquisition by a corporate buyer, and is expected to follow customary regulatory and closing conditions under the merger agreement.